Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000528:radiation effects; D000921:Antibody-Producing Cells / Q000187:drug effects; D001379:Azathioprine / Q000494:pharmacology; D002699:Chlorambucil / Q000494:pharmacology; D006084:Graft Rejection / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008722:Methods; D008775:Methylprednisolone / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D011830:Radiation Effects; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology*; D013156:Splenectomy; D013743:Tetanus Antitoxin / Q000096:biosynthesis; D013745:Tetanus Toxoid; D014181:Transplantation Immunology; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D002699:Chlorambucil; D001379:Azathioprine; D008775:Methylprednisolone